Search details
1.
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
N Engl J Med
; 384(3): 229-237, 2021 01 21.
Article
in English
| MEDLINE | ID: mdl-33113295
2.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med
; 385(15): 1382-1392, 2021 10 07.
Article
in English
| MEDLINE | ID: mdl-34260849
3.
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
; 75(1): e440-e449, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34718468
4.
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma.
Cancer
; 127(3): 372-380, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-33107983
5.
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer.
Invest New Drugs
; 39(1): 193-201, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32915419
6.
A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 39(4): 1089-1098, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33686452
7.
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 325(7): 632-644, 2021 02 16.
Article
in English
| MEDLINE | ID: mdl-33475701
8.
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma.
Cancer Sci
; 109(12): 3962-3970, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30353601
9.
Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
Am J Surg Pathol
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38809272
10.
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.
Cancers (Basel)
; 15(19)2023 Oct 06.
Article
in English
| MEDLINE | ID: mdl-37835565
11.
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
Arch Pathol Lab Med
; 146(3): 351-359, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34232984
12.
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma.
Mol Cancer Ther
; 20(1): 132-141, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33177152
13.
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
Front Oncol
; 10: 578756, 2020.
Article
in English
| MEDLINE | ID: mdl-33194700
14.
The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Cancer Discov
; 10(8): 1174-1193, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32404308
15.
Visual vignette.
Endocr Pract
; 20(5): 518, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24449681
16.
Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
Mod Pathol
; 21(12): 1461-9, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-18820665
17.
The future of oncology treatment through diagnostic testing.
MLO Med Lab Obs
; 45(12): 38, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24409595
18.
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
Eur J Cancer
; 103: 88-97, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30218977
19.
Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α.
Clin Cancer Res
; 24(4): 847-857, 2018 02 15.
Article
in English
| MEDLINE | ID: mdl-29191969
20.
"Simple Mucinous Cyst" of the Pancreas: A Clinicopathologic Analysis of 39 Examples of a Diagnostically Challenging Entity Distinct From Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms.
Am J Surg Pathol
; 41(1): 121-127, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27740966